4//SEC Filing
Ricardo Alonso 4
Accession 0001104659-19-047563
CIK 0001481512other
Filed
Aug 26, 8:00 PM ET
Accepted
Aug 27, 6:00 PM ET
Size
5.2 KB
Accession
0001104659-19-047563
Insider Transaction Report
Form 4
Ricardo Alonso
See Remarks
Transactions
- Sale
COMMON STOCK
2019-08-23$27.89/sh−2,285$63,740→ 9,143 total
Footnotes (2)
- [F1]The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 21, 2019.
- [F2]The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $27.49 to $28.39. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Ra Pharmaceuticals, Inc.
CIK 0001481512
Entity typeother
Related Parties
1- filerCIK 0001768722
Filing Metadata
- Form type
- 4
- Filed
- Aug 26, 8:00 PM ET
- Accepted
- Aug 27, 6:00 PM ET
- Size
- 5.2 KB